Jafron Biomedical Co.,Ltd. Financials

Market Capitalization CN¥17.21 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	23.17
Forward PE	12.83
Price to Sales TTM	CN¥6.94
Price to Book MRQ	CN¥4.72
Enterprise to Revenue	6.26
Enterprise to EBITDA	15.33

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	29.19%
Operating Margin	41.96%
Return on Assets TTM	9.57%
Return on Equity TTM	21.24%

Income Statement

Revenue TTM	CN¥2,480,819,968
Revenue per Share TTM	CN¥3.18
Quarterly Revenue Growth	-26.40%
Gross Profit TTM	CN¥2,013,684,352
EBITDA	CN¥951,136,007
Net Income to Common TTM	CN¥724,212,864
Diluted EPS TTM	CN¥0.93
Quarterly Earnings Growth YoY	-33.70%

Balance Sheet

Total Cash MRQ	CN¥2,587,133,952
Total Cash per Share MRQ	CN¥3.34
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	39.89
Current Ratio MRQ	3.94
Book Value per Share MRQ	CN¥4.56

Cash Flow

Operating Cash Flow TTM	CN¥812,946,944
Levered Free Cash Flow TTM	CN¥351,561,120

300529 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	798,605,275
Float Shares	374,233,851
Avg 10 Volume	4,491,414
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.02%
% Held by Institutions	11.57%

Stock Price Summary

Beta	0.46
Fifty Two Week Low	CN¥20.73
Fifty Two Week High	CN¥39.24
Fifty Two Week Change	-16.13%
Day 50 MA	CN¥21.64
Day 200 MA	CN¥26.63

Dividends and Splits

Forward Annual Dividend Rate	CN¥3.20
Forward Annual Dividend Yield	13.80%
Trailing Annual Dividend Rate	CN¥0.80
Trailing Annual Dividend Yield	3.45%
Payout Ratio	42.94%
Dividend Date
Ex Dividend Date	2025-05-26
Last Split Factor
Last Split Date	2020-05-20